Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies

Clinical trial NCT05705570 · RECRUITING

Trial details

NCT number: NCT05705570
Sponsor: Nelson Hamerschlak
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia, in Relapse Acute Lymphoblastic Leukemia Refractory B-cell Lymphoma Recurrent B-cell Lymphoma Refractory Chronic Lymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia Refractory

Start date: 2023-02-07
Primary completion: 2028-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.